ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Facial nerve canal paragangliomas: a reconstruction-focused management approach and proposed decision-making framework.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate outcomes of early integration of facial nerve management for facial nerve canal paragangliomas (FNC PGLs), prioritising facial nerve rehabilitation alongside tumour control.
methodsA retrospective case series was conducted at the Sydney Head and Neck Cancer Institute and Sydney Facial Nerve Service, Chris O'Brien Lifehouse. Three patients with FNC PGLs underwent multidisciplinary assessment including imaging, biochemical evaluation, and SDHx genetic testing. Surgical planning integrated tumour treatment with facial nerve reconstruction. Dynamic procedures (cross-facial nerve grafts, masseteric and hypoglossal transfers, interpositional grafts) were combined with static techniques (tensor fascia lata slings, eyelid weights, brow lifts). Outcomes were assessed using House-Brackmann (HB) grading, Speech Handicap Index (SHI), Oral Competence Questionnaire (OCQ), speech intelligibility, and speech error analysis.
resultsAll patients demonstrated improved facial nerve function, from preoperative HB grades IV-VI to HB III postoperatively, with a mean time to movement of 7 months (SD 4). Mean speech intelligibility improved from 78.3% to 86.7%, with corresponding improvements in SHI and OCQ scores. Static procedures restored resting symmetry, eye closure, and midface tone, while dynamic reanimation enabled spontaneous or volitional movement. No major treatment-related complications occurred. Tumour control was maintained in all patients at 60-68 months follow-up.
conclusionEarly integration of facial nerve management in FNC PGLs may attain durable tumour control while achieving meaningful improvement in facial nerve function. Early integration of facial nerve rehabilitation within a multidisciplinary framework improves oncologic and functional outcomes. LEVEL OF EVIDENCE: Level 4.
Indexed as
Identifiers
42543428What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.